TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 4 | 1 | 4 | 7 | 7 | 20 | 39 | 13 |
| S | %wins | 50 | 50 | 25 | 25 | 0 | 0 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/18/13 16:20 | 9/16/13 | PFE | Pfizer Inc | DE | Health | Drug | Pharmaceutical Preparations | Lewis-Hall Freda C | NY | O | EVP | S | -1,104 | 28.70 | 33 | -38 | -24 | 122 | D | 67 | 22 | 4 | -2 | -2 | 2 | 1 | 1 | -1 | -1 | 3 | 5 | 11 | 8 |
3/20/09 14:12 | 3/19/09 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Lewis-Hall Freda C | MA | O | EVP,Medi | S | -36 | 29.11 | 33 | -1 | -2 | 53 | 3 | 3 | -6 | 12 | 29 | 46 | |||||||||
12/22/08 11:50 | 12/19/08 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Lewis-Hall Freda C | MA | O | EVP,Medi | S | -37 | 29.90 | 33 | -1 | -3 | 43 | D | -22 | 19 | -6 | 8 | 7 | 41 | 19 | 7 | -3 | -4 | 4 | -2 | 13 | 41 |
12/12/08 11:02 | 12/10/08 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Lewis-Hall Freda C | MA | O | EVP,Medi | S.m | -33 | 26.00 | 33 | -1 | -3 | 44 | D | -40 | -2 | -27 | -9 | 0 | 11 | 12 | -2 | 5 | 18 | 27 | 11 | 26 | 62 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |